Results 261 to 270 of about 693,900 (279)

PARP inhibitors in ovarian cancer: Current status and future promise

Gynecologic Oncology, 2014
Panagiotis Konstantinopoulos, Ursula Matulonis, Joyce Liu   +2 more
exaly  

PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers

Journal of Clinical Medicine, 2019
Jaydutt V Vadgama
exaly  

POTENT PARP INHIBITORS

2009
PENNING THOMAS D, THOMAS SHEELA A, HAJDUK PHILIP J, SAUER DARYL R, SARRIS KATHY, GIRANDA VINCENT L   +5 more
openaire   +2 more sources

Pyrazoloquinolones are potent parp inhibitors

2007
PENNING THOMAS D, ZHU GUI-DONG, GANDHI VIRAJKUMAR B, GONG JIANCHUN, GIRANDA VINCENT L   +4 more
openaire   +5 more sources

PARP Inhibitors

2006
openaire   +1 more source

PARP inhibitors in cancer therapy: Two modes of attack on the cancer cell widening the clinical applications

Drug Resistance Updates, 2009
Yvette Drew, Ruth Plummer
exaly  

Phthalazine derivatives as parp inhibitors

2006
MEVELLEC LAURENCE ANNE, LUDO EDMOND J K, MERTENS JOSEPHUS CAROLUS, VAN DUN JACOBUS A J, SOMERS MARIA V F, WOUTERS WALTER B L   +5 more
openaire   +5 more sources

PARP Inhibitors

2008
openaire   +1 more source

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Jennifer Litton, Nicolas Sayegh, Chadi Hage Chehade   +2 more
exaly  

PARP Inhibitors

2017
openaire   +1 more source